Abstract:Apolipoprotein E (APOE) is a risk factor for late-onset Alzheimer's disease (AD). APOE4/4 homozygosity increases AD risk by >10-fold. Although an association between the APOE ε4allele and increased risk has been established, the mechanism by which APOE4 increases disease risk is poorly understood. Here, we hypothesize that APOE4 contributes to disease risk through both cell autonomous and non-cell autonomous mechanisms. We have optimized protocols to develop pure populations of human induced pluripotent stem cells (iPSCs)-derived astrocytes and neurons, determined by immunohistochemistry and global gene expression. For molecular and functional characterization we have established a co-culture system of astrocytes and neurons and measured their activities by the multi-electrode array (MEA), inflammatory and calcium-based assays. APOE4/4 or APOE3/3 iPSCs are being engineered to generate isogenic lines using CRISPR/Cas9 genome-editing. We will then use our differentiation and co-culture strategy to test the impact of APOE genotype in isogenic lines on neuronal and astrocyte gene expression and function. We have developed a protocol to efficiently and reproducibly generate pure populations of astrocytes and neurons from iPSC-derived neuroprogenitor cells (NPCs). Our iPSC-astrocytes are positive for astrocyte markers including S100B, GFAP, GLAST and ALdh1L1. Quantitative PCR confirmed decreased expression of neuronal markers such as TUJ1, MAP2, RELN and CACNA1C. RNAseq comparisons show that iPSC-astrocytes cluster with human fetal astrocytes and not with the source NPCs or matched NPC-derived neurons. Using the MEA platform, we have shown that co-culture of iPSC-excitatory neurons with iPSC-astrocytes is sufficient to improve the neuronal firing of co-cultured iPSC-neurons. iPSC-astrocytes secrete IL-6 in response to treatment with poly I:C, LPS or Ab42 and have constant waves of calcium signals in a manner similar to primary astrocytes. This established co-culture system will be applied to astrocytes and neurons differentiated from APOE4/4 and isogenic APOE3/3iPSC lines. Our optimized differentiation protocol gives consistent results across multiple lines, and significant changes are observed in neuronal activity as a consequence of co-culture of neurons with astrocytes. We are currently co-culturing astrocytes and neurons of different APOE genotypes to determine the impact of APOE4/4 astrocytes on isogenic APOE3/3 neuronal gene expression and activity.

EXPLORING CELL AUTONOMOUS AND NON-CELL AUTONOMOUS EFFECTS OF APOE GENOTYPE IN IPSC-DERIVED ASTROCYTES AND NEURONS

APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer’s Disease Phenotypes in Human iPSC-Derived Brain Cell Types

APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer’s disease patient iPSC-derived cerebral organoids

Cholesterol and matrisome pathways dysregulated in astrocytes and microglia

Inhibitory roles of Apolipoprotein E Christchurch astrocytes in curbing tau propagation using human pluripotent stem cell-derived models

APOE4 increases energy metabolism in APOE-isogenic iPSC-derived neurons

APOE4 impacts cortical neurodevelopment and alters network formation in human brain organoids

β-Amyloid species production and tau phosphorylation in iPSC-neurons with reference to neuropathologically characterized matched donor brains

Human Ipsc-Derived Neurons and Astrocytes As Models of Neurodegeneration, Neuroinflammation and Vesicular Trafficking in Alzheimer's Disease

Chimeric cerebral organoids reveal the essentials of neuronal and astrocytic APOE4 for Alzheimer's tau pathology

Mutual interaction of neurons and astrocytes derived from iPSCs with APP V717L mutation developed the astrocytic phenotypes of Alzheimer’s disease

Chimeric cerebral organoids reveal the essentials of neuronal and astrocytic APOE4 for Alzheimer’s tau pathology

[P3–170]: HUMAN IPSC‐DERIVED ALZHEIMER's DISEASE ASTROCYTES RECAPITULATE DISEASE‐RELATED PHENOTYPES

Contributions of genetic variation in astrocytes to cell and molecular mechanisms of risk and resilience to late onset Alzheimer's disease

Proteomic analysis reveals APOE isoform-specific regulation of ribosomes in neural precursor cells

ApoE4 disrupts intracellular trafficking and iron homeostasis in an improved iPSC-based model of human brain endothelial cells

Culture Variabilities of Human iPSC-Derived Cerebral Organoids Are a Major Issue for the Modelling of Phenotypes Observed in Alzheimer’s Disease

Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector

Cell type-specific roles of APOE4 in Alzheimer disease

APOE4 Impairs Microglia ‐ Astrocyte Crosstalk in Alzheimer Disease